Monsanto’s (MON) Hold Rating Reaffirmed at Barclays PLC
Other equities analysts also recently issued research reports about the stock. Piper Jaffray Cos. restated an overweight rating and set a $127.00 price objective (up previously from $95.00) on shares of Monsanto in a report on Monday, June 13th. Argus reiterated a buy rating and issued a $128.00 target price (up previously from $111.00) on shares of Monsanto in a research report on Wednesday, June 15th. Vetr upgraded Monsanto from a buy rating to a strong-buy rating and set a $122.43 target price on the stock in a research report on Tuesday, August 9th. Goldman Sachs Group Inc. set a $92.00 target price on Monsanto and gave the company a sell rating in a research report on Monday, June 27th. Finally, JPMorgan Chase & Co. upgraded Monsanto from a neutral rating to an overweight rating and set a $128.00 target price on the stock in a research report on Wednesday, September 21st. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of Buy and an average target price of $114.67.
Monsanto (NYSE:MON) traded up 0.07% during midday trading on Thursday, reaching $103.57. 974,005 shares of the company’s stock were exchanged. Monsanto has a 52 week low of $83.73 and a 52 week high of $114.26. The firm has a market capitalization of $45.32 billion, a price-to-earnings ratio of 45.59 and a beta of 1.19. The firm’s 50 day moving average is $104.88 and its 200 day moving average is $101.34.
Monsanto (NYSE:MON) last posted its quarterly earnings data on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.02) by $0.09. Monsanto had a net margin of 9.89% and a return on equity of 46.07%. The firm had revenue of $2.56 billion for the quarter, compared to the consensus estimate of $2.38 billion. During the same quarter in the prior year, the company posted ($0.19) earnings per share. The company’s revenue for the quarter was up 8.8% compared to the same quarter last year. On average, equities analysts anticipate that Monsanto will post $4.89 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, October 7th will be paid a $0.54 dividend. The ex-dividend date is Wednesday, October 5th. This represents a $2.16 dividend on an annualized basis and a yield of 2.09%. Monsanto’s dividend payout ratio is presently 71.05%.
In other Monsanto news, COO Brett D. Begemann sold 27,980 shares of the business’s stock in a transaction that occurred on Thursday, July 14th. The shares were sold at an average price of $103.62, for a total value of $2,899,287.60. Following the completion of the transaction, the chief operating officer now owns 102,480 shares of the company’s stock, valued at approximately $10,618,977.60. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Michael K. Stern sold 12,797 shares of the business’s stock in a transaction that occurred on Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the completion of the transaction, the chief executive officer now directly owns 21,583 shares of the company’s stock, valued at approximately $2,196,501.91. The disclosure for this sale can be found here. 0.88% of the stock is currently owned by company insiders.
Institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in Monsanto by 1.3% in the second quarter. Vanguard Group Inc. now owns 30,430,570 shares of the company’s stock worth $3,146,826,000 after buying an additional 389,914 shares in the last quarter. State Street Corp boosted its stake in shares of Monsanto by 0.9% in the first quarter. State Street Corp now owns 18,623,044 shares of the company’s stock worth $1,634,002,000 after buying an additional 173,201 shares during the period. FMR LLC boosted its stake in shares of Monsanto by 41.3% in the second quarter. FMR LLC now owns 16,593,757 shares of the company’s stock worth $1,715,960,000 after buying an additional 4,851,499 shares during the period. Massachusetts Financial Services Co. MA boosted its stake in shares of Monsanto by 0.3% in the second quarter. Massachusetts Financial Services Co. MA now owns 14,893,956 shares of the company’s stock worth $1,540,185,000 after buying an additional 38,316 shares during the period. Finally, Capital International Investors boosted its stake in shares of Monsanto by 6.2% in the second quarter. Capital International Investors now owns 8,187,701 shares of the company’s stock worth $846,690,000 after buying an additional 476,848 shares during the period. 79.02% of the stock is owned by institutional investors and hedge funds.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.